GlassScriptPhysician profile
James C Cord
NPI 1376522284
$4,672.80
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,926 · 2020: $2,068 · 2021: $678.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,821.38 | 2020-2021 | |
| Neotract INC. | $1,619.24 | 2019-2020 | |
| Pfizer INC. | $234.26 | 2019-2021 | |
| Clarus Therapeutics INC. | $209.52 | 2021 | |
| Astellas Pharma US INC | $191.07 | 2019-2021 | |
| Abbvie INC. | $98.74 | 2020-2021 | |
| Allergan, INC. | $69.37 | 2020-2021 | |
| Janssen Biotech, INC. | $53.43 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $46.96 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $37.24 | 2019-2021 | |
| Boston Scientific Corporation | $36.12 | 2020-2021 | |
| Hollister Incorporated | $34.03 | 2021 | |
| Smith+Nephew, INC. | $31.64 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $30.91 | 2020 | |
| Coloplast Corp | $28.29 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $24.16 | 2019 | |
| 180 Medical, INC. | $22.19 | 2019 | |
| Myovant Sciences INC. | $20.00 | 2021 | |
| Antares Pharma, INC. | $18.28 | 2020 | |
| Axonics, INC. | $17.74 | 2021 | |
| Ethicon US, LLC | $16.05 | 2019 | |
| Endo Pharmaceuticals INC. | $12.18 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cord listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.